Acupuncture for Anxiety in Parkinson's Disease
Acupuncture as a Symptomatic Treatment for Anxiety in Parkinson's Disease
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
This is a single-center, double-blind, placebo-controlled trial to see if acupuncture can safely and effectively manage anxiety in Parkinson's Disease. Eligible subjects will receive either real or sham acupuncture THREE times weekly for a total of SIX weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Oct 2021
Typical duration for not_applicable parkinson-disease
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2021
CompletedFirst Posted
Study publicly available on registry
January 28, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedFebruary 2, 2021
January 1, 2021
1.9 years
January 25, 2021
January 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in the Hamilton Anxiety Scale (HAM-A) between the treatment group.
The primary outcome measure will be the change between the baseline visit and the SIX-week time point in the Hamilton Anxiety Scale (HAM-A) between the treatment group. Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where \<17 indicates mild severity, 18-24 mild to moderate severity, and 25-30 moderate to severe.
SIX weeks
Change in the Generalized Anxiety Disorder 7-Item (GAD-7) scale between the treatment group.
The primary outcome measure will be the change between the baseline visit and the SIX-week time point in the Generalized Anxiety Disorder 7-Item (GAD-7) scale between the treatment group. Each item is scored on a scale of 0 (not at all) to 3 (Nearly Every Day), with a total score range of 0-56, where \<4 indicates Minimal Anxiety, 5-9 Mild Anxiety, 10-14 Moderate Anxiety, and 15-21 Severe Anxiety.
SIX Weeks
Secondary Outcomes (1)
Change in the Unified Parkinson's Disease Rating Scale between the treatment group.
THREE months
Study Arms (2)
Randomized Subjects receive a sham acupuncture.
SHAM COMPARATORSubjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.
Randomized Subjects receive a real acupuncture.
ACTIVE COMPARATORSubjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.
Interventions
Subjects will be randomized in a 1:1 ratio to receive sham acupuncture.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with Parkinson's Disease by authorized Neurologist.
- Patients 40-75 years of age
- Patients who have significant anxiety symptom
- Patients must be on a stable medication regimen for the treatment of PD
You may not qualify if:
- Patients who have had previous acupuncture within the past SIX months
- Patients with dementia, depression, or sleep disorder
- Patients who are currently taking medications known to affect anxiety
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 25, 2021
First Posted
January 28, 2021
Study Start
October 1, 2021
Primary Completion
September 1, 2023
Study Completion
May 1, 2024
Last Updated
February 2, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR